SpectraScience, Inc.
SCIE · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.01 | 0.00 | 0.00 |
| FCF Yield | -16.50% | -44.16% | -29.34% | 0.00% |
| EV / EBITDA | -9.46 | -8.76 | -10.60 | -5.90 |
| Quality | ||||
| ROIC | 7.81% | 11.62% | 14.34% | 25.21% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.06 | 0.16 | 0.19 | 0.17 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -46.97% | -31.70% | -31.70% |
| Free Cash Flow Growth | 51.06% | -2.92% | 27.83% | 27.34% |
| Safety | ||||
| Net Debt / EBITDA | -8.80 | -8.28 | -9.75 | -5.90 |
| Interest Coverage | -0.65 | -1.91 | -2.63 | -3.56 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 2.17 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -562.69 |